Back to search

Article

Blood biomarker changes in response to low-dose oral ketamine treatment in adults with major depressive disorder (MDD) and post-traumatic stress disorder (PTSD)

2026-08-14

Abstract excerpt

Major depressive disorder (MDD) and post-traumatic stress disorder (PTSD) are prevalent, chronic, and disabling mental health conditions which are difficult to treat. Ketamine has demonstrated effect for improving depression and PTSD symptoms independently but reports often overlook focused comorbid improvement of these symptoms within individuals. To address this, we assessed blood-based biomarker and psychologic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b4ac4639-5a93-54e8-bbd8-01692f5102cc
DOI
10.64898/2026.08.12.26360216
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Blood biomarker changes in response to low-dose oral ketamine treatment in adults with major depressive disorder (MDD) and post-traumatic stress disorder (PTSD)DOI 10.64898/2026.08.12.26360216
Combined Ketamine and Psychotherapy Provide No Additional Benefit Beyond Ketamine Alone in Treating Depression or PTSD: Evidence from a Help-Seeking SampleSemantic proximity
Ketamine-assisted psychotherapy provides lasting and effective results in the treatment of depression, anxiety and post traumatic stress disorder at 3 and 6 months: Findings from a large single-arm retrospective effectiveness trialSemantic proximity
Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study.Semantic proximity
Real-world patient characteristics, treatment patterns, efficacy and safety of intramuscular ketamine treatment: a retrospective cohort studySemantic proximity
To Predict, Prevent, and Manage Post-Traumatic Stress Disorder (PTSD): A Review of Pathophysiology, Treatment, and Biomarkers.Semantic proximity
Cytokine- and Vascular Endothelial Growth Factor-Related Gene-Based Genome-Wide Association Study of Low-Dose Ketamine Infusion in Patients with Treatment-Resistant DepressionSemantic proximity
Brain-epigenome wide association study (BEWAS) on the effects of two emerging psychedelics: ketamine & MDMASemantic proximity
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets.Semantic proximity
Ketamine in severe, highly treatment-resistant depression—a retrospective case study and a perspectiveSemantic proximity
Methylome and transcriptome functional analysis identifies key biomarkers in ketamine’s sustained therapeutic effect on PTSDSemantic proximity
A review of new insights into existing major depressive disorder biomarkersSemantic proximity
Randomized trial, parallel-group to compare effect of low-intensity transcranial magnetic stimulation (Li-TMS) on sleep disorders, inflammation levels, and brain-derived neurotrophic factor in patients with depressionSemantic proximity
Select a neighboring publication to make it the new centre.